Increasing being pregnant AI options entry to Southeast Asia and extra briefs

Increasing being pregnant AI options entry to Southeast Asia and extra briefs

Indian startup brings pregnancy AI solutions to rural Vietnam, Laos Women’s health startup Doto Health from India has entered into a strategic partnership to expand across Southeast Asia. It signed a memorandum of understanding with human development organisation FHI 360, Alive & Thrive, which is a global program focused on mother, child, and youth nutrition, … Read more

Increasing being pregnant AI options entry to Southeast Asia and extra briefs

Increasing being pregnant AI options entry to Southeast Asia and extra briefs

Indian startup brings pregnancy AI solutions to rural Vietnam, Laos Women’s health startup Doto Health from India has entered into a strategic partnership to expand across Southeast Asia. It signed a memorandum of understanding with human development organisation FHI 360, Alive & Thrive, which is a global program focused on mother, child, and youth nutrition, … Read more

RadNet acquires See-Mode Applied sciences for entry, income development

RadNet acquires See-Mode Applied sciences for entry, income development

Diagnostic imaging company RadNet, via DeepHealth, its wholly-owned subsidiary, has acquired AI ultrasound imaging company See-Mode Technologies.   See-Mode’s AI-powered ultrasound detection, characterization and reporting application for thyroid and breast will be integrated into RadNet’s DeepHealth population health offerings.  According to RadNet, See-Mode’s original applications for detecting and characterizing thyroid nodules and breast lesions in ultrasound … Read more

Proper to Attempt vs. Expanded Entry: What Sufferers Must Know

Proper to Attempt vs. Expanded Entry: What Sufferers Must Know

When facing a life-threatening condition with no approved treatment options, patients and their families often find themselves navigating complex regulatory pathways in search of experimental therapies. Two distinct routes exist for accessing investigational treatments outside of clinical trials: the FDA’s long-established Expanded Access Program, also known as compassionate use, and the newer Right to Try … Read more